-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million.
  • BeyondSpring (NASDAQ:BYSI) stock moved upwards by 26.74% to $0.82. The company's market cap stands at $26.4 million.
  • Genenta Science (NASDAQ:GNTA) stock rose 25.35% to $0.78. The company's market cap stands at $14.4 million.
  • Acumen Pharmaceuticals (NASDAQ:ABOS) shares moved upwards by 21.98% to $0.26. The company's market cap stands at $15.1 million.
  • IDEXX Laboratories (NASDAQ:IDXX) stock increased by 19.75% to $660.13. The market value of their outstanding shares is at $43.4 billion. As per the news, the Q3 earnings report came out today.
  • InspireMD (NASDAQ:NSPR) shares rose 19.39% to $0.54. The market value of their outstanding shares is at $21.0 million.

Losers

  • Karyopharm Therapeutics (NASDAQ:KPTI) shares decreased by 83.5% to $0.11 during Monday's regular session. The market value of their outstanding shares is at $15.0 million.
  • Bright Minds Biosciences (NASDAQ:DRUG) stock fell 59.83% to $22.09. The company's market cap stands at $539.4 million.
  • Jaguar Health (NASDAQ:JAGX) stock declined by 49.09% to $0.82. The company's market cap stands at $3.7 million.
  • NeuroSense Therapeutics (NASDAQ:NRSN) shares fell 42.74% to $1.14. The market value of their outstanding shares is at $3.7 million.
  • Nordicus Partners (NASDAQ:NORD) shares fell 28.34% to $3.52. The company's market cap stands at $95.5 million.
  • GlucoTrack Inc (NASDAQ:GCTK) shares fell 27.79% to $0.58. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending